| This article has been cited by |
| 1 | Neutron-activated theranostic radionuclides for nuclear medicine | |
| Hun Yee Tan,Chai Hong Yeong,Yin How Wong,Molly McKenzie,Azahari Kasbollah,Mohamad Nazri Md. Shah,Alan Christopher Perkins |
| Nuclear Medicine and Biology.2020;90-91()55 |
| [DOI] |
|
| 2 | 177Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India | |
| Madhav Danthala,K. G. Kallur,G. R. Prashant,K. Rajkumar,M. Raghavendra Rao |
| European Journal of Nuclear Medicine and Molecular Imaging.2014;41(7)1319 |
| [DOI] |
|
| 3 | Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications | |
| Sharmila Banerjee,M. R. A. Pillai,F. F. (Russ) Knapp |
| Chemical Reviews.2015;115(8)2934 |
| [DOI] |
|
| 4 | Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications | |
| Lisa Blackberg,Salar Sajedi,Owen A. Anderson,Yuemeng Feng,Georges El Fakhri,Lars Furenlid,Hamid Sabet |
| Chemical Reviews.2020;115(8)1 |
| [DOI] |
|
| 5 | Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications | |
| J.A. Peters,K. Djanashvili,C.F.G.C. Geraldes |
| Chemical Reviews.2017;115(8)261 |
| [DOI] |
|
| 6 | HEDEFE YÖNELIK TEDAVIDE GÜNCEL YAKLASIMLAR: LUTESYUM-177 ILE ISARETLI RADYOFARMASÖTIKLER | |
| Dorukhan HISIR,Meliha EKINCI,Derya ILEM-ÖZDEMIR |
| Ankara Universitesi Eczacilik Fakultesi Dergisi.2022;115(8)209 |
| [DOI] |
|
| 7 | Gamma radiation exposure of accompanying persons due to Lu-177 patients | |
| Bilal Kovan,Bayram Demir,Duygu Tuncman,Veli Capali,Cuneyt Turkmen,E. Tel,A. Aydin,A. Kaplan,I.H. Sarpün |
| EPJ Web of Conferences.2015;100(8)03002 |
| [DOI] |
|
| 8 | Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer | |
| Natalia Herrero Álvarez,David Bauer,Javier Hernández-Gil,Jason S. Lewis |
| ChemMedChem.2021;16(19)2909 |
| [DOI] |
|
